This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Nontuberculous Mycobacterium Treatment Market

Market Insights on Nontuberculous Mycobacterium Treatment covering sales outlook, demand forecast & up-to-date key trends

Nontuberculous Mycobacterium Treatment Market: Global Industry Analysis 2016 - 2020 and Opportunity Assessment 2021 - 2031

Nontuberculous Mycobacterium Treatment Market Overview

According to the latest research by Future Market Insights, the nontuberculous mycobacterium treatment market will witness growth during 2021-2031. These are the non-motile, acid fast bacilli which are mostly seen soil and water.

According to CDC, NTM has the ability to affect certain group of people which have underlying lung diseases or are immunocompromised. The market is expected to grow due to the rising ageing population, chronic disorders and rising R&D. Globally there are on an average 7m cases of NTM which opens the window for expansion of the market in the given forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

What is driving Demand for Nontuberculous Mycobacterium Treatment Market?

The demand for Nontuberculous Mycobacterium treatment market has seen at a higher rate at a global level as there has increase in the number of chronic disease. Aging population, immunocompromised patients, and lifestyle can also be reasons to drive the market demand.

Furthermore, Pharma companies are involving in manufacturing nontuberculous mycobacterium antibiotics as the disease population strikes a growth globally. Pharma companies including RedHill Biopharma, Insmed Incorporated, Novoteris, Beyond Air, Savara, and others are exploring novel therapeutic approaches to treat nontuberculous mycobacterium infection.

The launch of emerging therapies in the nontuberculous mycobacterium infection pipeline including Thiolanox, RHB-204, Molgradex, Nitric Oxide, and Arikayce is expected to add value to the present nontuberculous mycobacterial infection during the forecast period. Of the emerging therapies, the most anticipated therapy in the nontuberculous mycobacterium infections market to get launched is, Insmed Incorporated launch Arikayce, an aminoglycoside for the treatment of NTM infection which was approved by FDA.

U.S. Nontuberculous Mycobacterium Treatment Market Outlook

U.S. is said to be the most dominating in terms of disease growth rate and will be the top one to boost the nontuberculous mycobacterium treatment market. The prevalence rate in infection of nontuberculous mycobacterium is at a higher side in the U.S.

This is due to the rising number of malignant diseases leading to immunocompromisation. In addition, rising R&D and technological advancement in the region are some of the drivers of nontuberculous mycobacterium treatment market.

Sabyasachi Ghosh
Principal Consultant
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Europe Demand Outlook for Nontuberculous Mycobacterium Treatment Market

The European market Germany and Italy is said to take hike in the market growth. There are many opportunities in this market as people consider treatments with short span, and effective. Healthcare department spending will lead the growth of the market. European medicines Agency has now up to the orphan drug i.e. they are marketing their ARIKACE which a is an inhalation drug in treating nontuberculous Mycobacterium.

EU issues such drugs so as to treat the life threatening diseases or Chronic in nature. Akrikace is set to market globally in the near future. European medicines Agency has shown a great initiation in marketing the product which is of great help for the population.

Who are the Key Manufacturers and Suppliers of Nontuberculous Mycobacterium treatment market

Some of the key players operating in the Nontuberculous Mycobacterium Treatment Market are

  • Insmed Incorporated, 
  • RedHill Biopharma, 
  • Novoteris,
  •  Savara, 
  • Beyond Air 

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Key Segment

By Drug Type:

  • Clarithromycin
  • Azithromycin
  • Rifampin
  • Rifabutin
  • Ethambutol
  • Streptomycin
  • Amikacin.

By End User:

  • Hospitals Pharmacies
  • Private clinics
  • Drug stores and retail pharmacy
  • E-commerce

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa
Table of Content


Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables


Sabyasachi Ghosh
Principal Consultant
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts


Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Nontuberculous Mycobacterium Treatment Market